Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Equitable A Pref | EQH-A | Apr 25, 2024 | 21.77 | -0.50 |
Equitable C Pref | EQH-C | Apr 25, 2024 | 17.56 | -1.84 |
Equitable Holdings | EQH | Apr 25, 2024 | 37.13 | -2.47 |
Equitrans Midstream | ETRN | Apr 25, 2024 | 13.72 | +2.08 |
Equity Bancshares A | EQBK | Apr 25, 2024 | 33.64 | -0.94 |
Equity Commonwealth | EQC | Apr 25, 2024 | 18.62 | -0.21 |
Equity Commonwealth D Pref | EQC-D | Apr 25, 2024 | 25.04 | -0.09 |
Equity Income Wisdomtree | DHS | Apr 25, 2024 | 84.44 | -1.04 |
Equity Lifestyle Properties | ELS | Apr 25, 2024 | 60.75 | -0.93 |
Equity Residential | EQR | Apr 25, 2024 | 64.88 | +0.42 |
Equus Total Return | EQS | Apr 25, 2024 | 1.48 | +0.68 |
Era Group | VTOL | Apr 25, 2024 | 26.12 | +0.04 |
Erasca | ERAS | Apr 25, 2024 | 1.88 | 0.00 |
Erayak Power Solution Group A | RAYA | Apr 25, 2024 | 0.65 | +0.18 |
Ericsson B ADR | ERIC | Apr 25, 2024 | 5.24 | -0.76 |
Erie Indemnity A | ERIE | Apr 25, 2024 | 380.26 | -0.63 |
Ermenegildo Zegna N.V. | ZGN | Apr 25, 2024 | 11.84 | -1.17 |
ESAB | ESAB | Apr 25, 2024 | 106.82 | -0.59 |
Escalade | ESCA | Apr 25, 2024 | 13.67 | -2.36 |
Esco Technologies | ESE | Apr 25, 2024 | 104.28 | 0.00 |
ESGL | ESGL | Apr 25, 2024 | 0.55 | -13.51 |
ESH Acquisition | ESHA | Apr 25, 2024 | 10.40 | 0.00 |
Esperion Therapeutics | ESPR | Apr 25, 2024 | 1.99 | -6.57 |
Espey Mfg & Electronics | ESP | Apr 25, 2024 | 22.64 | -0.53 |
Esquire Financial | ESQ | Apr 25, 2024 | 47.40 | +0.96 |
ESS Tech | GWH | Apr 25, 2024 | 0.71 | +0.43 |
ESSA Bancorp | ESSA | Apr 25, 2024 | 16.27 | -3.41 |
ESSA Pharma | EPIX | Apr 25, 2024 | 6.12 | -2.08 |
Essent Group | ESNT | Apr 25, 2024 | 53.86 | -0.57 |
Essential Properties Realty Trust | EPRT | Apr 25, 2024 | 25.73 | -2.28 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.